Clinical Trial Update: Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating exercise and/or liraglutide on vascular dysfunction and insulin sensitivity in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University of Virginia | Conditions: Type2 Diabetes | Phase 4 | Status: UNKNOWN